The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Pharmacists Raise Level of Care for Patients with Knee Osteoarthritis

Pharmacists Raise Level of Care for Patients with Knee Osteoarthritis

August 22, 2014 • By Richard Quinn

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Rheumatologists should consider pharmacists as a resource to help them provide better and more cost-effective care to patients with previously undiagnosed knee osteoarthritis (OA), according to the lead author of a new Canadian study on the topic.

You Might Also Like
  • Knee Injuries Associated with Accelerated Knee Osteoarthritis
  • Rheumatology Coding Corner Question: Level 3 Visit with Primary Diagnosis of Osteoarthritis
  • Exercise Therapy Recommended to Manage Knee Osteoarthritis
Also By This Author
  • Email Remains Dominant Communications Method in Medicine

The study, in Arthritis Care & Research, states that a pharmacist-initiated program involving multiple disciplines resulted in “good value for money from both the societal and the Ministry of Health perspectives.”1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Pharmacists are well positioned to provide care to patients with chronic diseases due to their accessibility and their frequency of contact,” writes lead author Carlo Marra, BSc, PharmD, PhD, in an e-mail to The Rheumatologist. They “are also uniquely trained among the healthcare team with very specialized medication knowledge across the full scope of diseases.”

Dr. Marra, dean of the School of Pharmacy at Memorial University in Newfoundland, Canada, says he wasn’t surprised the study found that the quality of care improved. “However, the secondary outcomes of improved quality of life and reducing overall healthcare expenditures were a bit surprising,” he writes.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The study reported that the program resulted in incremental cost-effectiveness ratios of $232 (95% confidence interval [CI]—1,530, 2,154) per quality-adjusted-life year (QALY) gained from the Ministry of Health perspective and $14,395 (95% CI—7,826, 23,132) per QALY gained from the societal perspective, versus usual care.

The intervention included the administration of a validated knee OA screening questionnaire, education, pain medication management, physiotherapy-guided exercise and communication with the client’s primary care physician, researchers report. Other findings include improvements in the Arthritis Foundation’s quality indicators of care pass rate (difference of 45.2%; 95% CI—34.5, 55.9) and “significant improvements in pain, function, and quality of life all favoring the multidisciplinary intervention,” study authors write.

Dr. Marra says he hopes the next step will be research into how a pharmacist-initiated, multidisciplinary care approach could affect other chronic conditions, such as inflammatory arthritis. He says he believes the Canadian study could spur similar efforts elsewhere.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“I think the results are exportable to other jurisdictions that have pharmacists participating in the care of patients,” he writes. “However, to have sustainable services that benefit patients, pharmacists would need to be reimbursed for their medication management skills.” (posted 8/22/14)

Richard Quinn is a freelance writer in New Jersey.

Reference
1. Marra CA, Grubisic M, Cibere J, et al. Cost-utility analysis of a multidisciplinary
strategy to manage osteoarthritis of the knee: Economic evaluation of a cluster randomized
controlled trial study. Arthritis Care Res (Hoboken). 2014;66(6):810–816
.

Pages: 1 2 | Multi-Page

Filed Under: Conditions, Osteoarthritis, Research Reviews Tagged With: Carlo Marra, Osteoarthritis, patient care, pharmacist, Quality, Treatment

You Might Also Like:
  • Knee Injuries Associated with Accelerated Knee Osteoarthritis
  • Rheumatology Coding Corner Question: Level 3 Visit with Primary Diagnosis of Osteoarthritis
  • Exercise Therapy Recommended to Manage Knee Osteoarthritis
  • Physical Therapy, Exercise Advances for Knee Osteoarthritis

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.